Literature DB >> 3023666

p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos.

B Singh, M Hannink, D J Donoghue, R B Arlinghaus.   

Abstract

A serine/threonine-specific protein kinase activity is closely associated with v-mos-encoded proteins. Experiments were conducted with several mutant forms of p37mos to determine whether or not the kinase function correlates with the biological activity of the mutant v-mos genes. Two mutants lacking cell transformation activity, one an arginine substitution for lysine-121 in the putative ATP-binding site and the other a 23-amino acid deletion from the C-terminal end of p37mos, had no kinase activity associated with their mutant proteins. However, a third mutant with reduced biological activity had drastically less kinase activity than the wild-type protein. The latter mutant was able to phosphorylate the kinase-inactive p37mos(Arg-121) protein in vitro. These results indicate that even though p37mos(Arg-121) can be phosphorylated in trans by other kinase molecules, it lacks the ability to phosphorylate itself in vitro. This provides a compelling argument that the protein kinase function of p37mos is an intrinsic property of the protein. Moreover, since the kinase function correlates with the cellular transformation activity of the v-mos gene, we predict that it is required for the biological activity of the v-mos gene.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023666      PMCID: PMC253371     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  A trans-acting protein kinase identified in cells transformed by Abelson murine leukemia virus.

Authors:  O N Witte; L Sun; N Rosenberg; D Baltimore
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

2.  Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus.

Authors:  J Papkoff; I M Verma; T Hunter
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

3.  Primary structure of v-raf: relatedness to the src family of oncogenes.

Authors:  G E Mark; U R Rapp
Journal:  Science       Date:  1984-04-20       Impact factor: 47.728

4.  Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein.

Authors:  J Sprague; J H Condra; H Arnheiter; R A Lazzarini
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

5.  P85gag-mos encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity.

Authors:  W S Kloetzer; S A Maxwell; R B Arlinghaus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

6.  Synthetic peptide substrates for the membrane tyrosine protein kinase stimulated by epidermal growth factor.

Authors:  C House; G S Baldwin; B E Kemp
Journal:  Eur J Biochem       Date:  1984-04-16

7.  Epidermal growth factor stimulates the phosphorylation of synthetic tyrosine-containing peptides by A431 cell membranes.

Authors:  L J Pike; B Gallis; J E Casnellie; P Bornstein; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Tyrosine protein kinase activity of rat spleen and other tissues.

Authors:  G Swarup; J D Dasgupta; D L Garbers
Journal:  J Biol Chem       Date:  1983-09-10       Impact factor: 5.157

9.  Synthetic peptide substrates for a tyrosine protein kinase.

Authors:  T Hunter
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

10.  Neither arginine nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src.

Authors:  M P Kamps; B M Sefton
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

View more
  14 in total

1.  Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation.

Authors:  R S Freeman; D J Donoghue
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

2.  mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities.

Authors:  N Yew; M Oskarsson; I Daar; D G Blair; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

3.  v-mos protein produced by in vitro translation has protein kinase activity.

Authors:  N K Herzog; M Nash; L S Ramagli; R B Arlinghaus
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

4.  The P55 protein affected by v-mos expression is vimentin.

Authors:  B Singh; R Goldman; L Hutton; N K Herzog; R B Arlinghaus
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

5.  Inhibition of v-Mos kinase activity by protein kinase A.

Authors:  Y Yang; C H Herrmann; R B Arlinghaus; B Singh
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

6.  Molecular cloning and characterization of a conserved nuclear serine(threonine) protein kinase.

Authors:  T Millward; P Cron; B A Hemmings
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

7.  v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant.

Authors:  B Singh; C Stocking; R Walker; Y D Yang; W Ostertag; R B Arlinghaus
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

8.  Mos oncogene product associates with kinetochores in mammalian somatic cells and disrupts mitotic progression.

Authors:  X M Wang; N Yew; J G Peloquin; G F Vande Woude; G G Borisy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

9.  Xenopus homolog of the mos protooncogene transforms mammalian fibroblasts and induces maturation of Xenopus oocytes.

Authors:  R S Freeman; K M Pickham; J P Kanki; B A Lee; S V Pena; D J Donoghue
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Evidence for the involvement of the proto-oncogene c-mos in mammalian meiotic maturation and possibly very early embryogenesis.

Authors:  G L Mutter; G S Grills; D J Wolgemuth
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.